NM_003998.4:c.40-910A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003998.4(NFKB1):​c.40-910A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.692 in 151,822 control chromosomes in the GnomAD database, including 36,893 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.69 ( 36893 hom., cov: 29)

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.831

Publications

15 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.789 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003998.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
NM_003998.4
MANE Select
c.40-910A>G
intron
N/ANP_003989.2
NFKB1
NM_001382625.1
c.40-910A>G
intron
N/ANP_001369554.1
NFKB1
NM_001382626.1
c.40-910A>G
intron
N/ANP_001369555.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NFKB1
ENST00000226574.9
TSL:1 MANE Select
c.40-910A>G
intron
N/AENSP00000226574.4
NFKB1
ENST00000394820.8
TSL:1
c.40-910A>G
intron
N/AENSP00000378297.4
NFKB1
ENST00000505458.5
TSL:1
c.40-910A>G
intron
N/AENSP00000424790.1

Frequencies

GnomAD3 genomes
AF:
0.692
AC:
104964
AN:
151702
Hom.:
36867
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.797
Gnomad AMI
AF:
0.702
Gnomad AMR
AF:
0.577
Gnomad ASJ
AF:
0.683
Gnomad EAS
AF:
0.575
Gnomad SAS
AF:
0.734
Gnomad FIN
AF:
0.629
Gnomad MID
AF:
0.745
Gnomad NFE
AF:
0.670
Gnomad OTH
AF:
0.690
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.692
AC:
105025
AN:
151822
Hom.:
36893
Cov.:
29
AF XY:
0.687
AC XY:
50979
AN XY:
74180
show subpopulations
African (AFR)
AF:
0.796
AC:
32959
AN:
41412
American (AMR)
AF:
0.576
AC:
8779
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.683
AC:
2367
AN:
3468
East Asian (EAS)
AF:
0.574
AC:
2955
AN:
5144
South Asian (SAS)
AF:
0.735
AC:
3528
AN:
4800
European-Finnish (FIN)
AF:
0.629
AC:
6622
AN:
10532
Middle Eastern (MID)
AF:
0.738
AC:
217
AN:
294
European-Non Finnish (NFE)
AF:
0.670
AC:
45495
AN:
67922
Other (OTH)
AF:
0.694
AC:
1464
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1581
3162
4742
6323
7904
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.676
Hom.:
4337
Bravo
AF:
0.689
Asia WGS
AF:
0.640
AC:
2231
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.72
DANN
Benign
0.51
PhyloP100
-0.83
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs230533; hg19: chr4-103450083; API